PIII · P3 Health Partners Inc. · Webcasts, Transcripts & Audio
$2.70
-0.05 (-1.82%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, we have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q are issued.”View the 10-Q filed Nov 9, 2026
Market Cap
$19.61M
Shares
7.26M
Volume · Nov 13
29.47K
Avg daily vol (3M)
30.21K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
P3 Health Partners Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for P3 Health Partners Inc. (PIII), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-09
P3 Health Partners Inc. (PIII) Q3 2026 Earnings Call Transcript
Confident tone
Medical cost and utilization management
Quality and clinical outcomes
Future earnings timing
Revenue
$396.34M
▲ 14.8% YoY Diluted EPS
$0.07
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-10
P3 Health Partners Inc. (PIII) Q2 2026 Earnings Call Transcript
Confident tone
Adjusted EBITDA and financial performance
Medical cost trend and utilization management
Guidance and back-half outlook
Revenue
$386.38M
▲ 8.6% YoY Diluted EPS
$-0.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
P3 Health Partners Inc. (PIII) Q1 2026 Earnings Call Transcript
Confident tone
Medical cost trend management
Payer contract restructuring and delegation
Adjusted EBITDA outperformance and raised outlook
Revenue
$386.39M
▲ 3.5% YoY Diluted EPS
$0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call
Revenue
$384.81M*
▲ 3.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-14
P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript
Cautious tone
Operational stabilization and EBITDA expansion opportunity
Revised guidance and prior-period adjustments
2026 rate environment and revenue outlook
Revenue
$345.25M
▼ 4.7% YoY Diluted EPS
$-9.67
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
P3 Health Partners Inc. (PIII) Q2 2025 Earnings Call Transcript
Positive tone
2026 opportunity and base rate increase
EBITDA improvement plan and profitability trajectory
Care enablement model and clinical programs
Revenue
$355.79M
▼ 6.2% YoY Diluted EPS
$-6.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
P3 Health Partners Inc. (PIII) Q1 2025 Earnings Call Transcript
Positive tone
2025 Guidance Reiteration
Membership and Network Rationalization
Per Member Funding and Risk Adjustment
Revenue
$373.23M
▼ 3.9% YoY Diluted EPS
$-6.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
P3 Health Partners Inc. (PIII) Q4 2024 Earnings Call
Revenue
$370.69M*
▲ 6.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript
Positive tone
Medicare Advantage Sector Headwinds
Value-Based Care Platform and Demand
Initiatives to Drive Profitability
Revenue
$362.12M
▲ 25.6% YoY Diluted EPS
$-15.70
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
P3 Health Partners Inc. (PIII) Q2 2024 Earnings Call Transcript
Positive tone
Financial performance and guidance
Medicare Advantage / value-based care market opportunity
Growth in ACO Reach
Revenue
$379.16M
▲ 15.2% YoY Diluted EPS
$-7.37
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
P3 Health Partners Inc. (PIII) Q1 2024 Earnings Call Transcript
Positive tone
Persistency and renewal
ACO REACH expansion
Adjusted EBITDA and profitability path
Revenue
$388.49M
▲ 28.6% YoY Diluted EPS
$-7.86
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-10
P3 Health Partners Inc. (PIII) Q4 2023 Earnings Call Transcript
Confident tone
Medical Margin and Utilization
Membership and Growth
Q4 2023 Miss and Reserve Adjustment
Revenue
$346.86M*
▲ 34.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
P3 Health Partners Inc. (PIII) Q3 2023 Earnings Call Transcript
Revenue
$288.35M
▲ 16.1% YoY Diluted EPS
$-6.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
P3 Health Partners Inc. (PIII) Q2 2023 Earnings Call Transcript
Revenue
$329.09M
▲ 22.1% YoY Diluted EPS
$-4.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
P3 Health Partners Inc. (PIII) Q1 2023 Earnings Call Transcript
Revenue
$302.08M
▲ 10.4% YoY Diluted EPS
$-11.00
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-11
P3 Health Partners Inc. (PIII) Q4 2022 Earnings Call Transcript
Revenue
$258.21M*
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-20
P3 Health Partners Inc. (PIII) Q3 2022 Earnings Call Transcript
Revenue
$248.26M
▲ 59% YoY Diluted EPS
$-13.50
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Date not confirmed
P3 Health Partners Inc. (PIII) Q2 2022 Earnings Call Transcript
Revenue
$269.45M
▲ 86.4% YoY Diluted EPS
$-186.50
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-14
P3 Health Partners Inc. (PIII) Q1 2022 Earnings Call
Revenue
$273.54M
▲ 80.8% YoY Diluted EPS
$-12.50
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–19 of 19 webcasts
Key facts
CIK
1832511
CUSIP
744413204
13F (30d)
27 filings
17 filers
Visit website
Investor relations